Results 101 to 110 of about 10,576 (193)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease

Кардиоваскулярная терапия и профилактика, 2008
Aim. To investigate endothelial dysfunction (ED) in patients with coronary heart disease (CHD), stable effort angina, Functional Class (FC) I-III, as well as to study perindopril potential in ED correction.Material and methods.
O. A. Vartanova, N. V. Mikhailova, T. E. Morozova   +2 more
doaj  

Table1_Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review.docx

Background: Uncontrolled blood pressure is a major risk factor for cardiovascular diseases. Fixed-dose combination (FDC) therapy offers a promising approach to addressing this challenge by providing a convenient single-tablet solution that enhances the ...
Le Huu Nhat Minh (6742229), Nguyen Thi Hai Yen (3804427), Le Nguyen Anh Thu (17930153), Quang-Hien Nguyen (17930183), Nguyen Tuan Phat (17930177), Nguyen Thi Quynh Nga (17930162), Uyen Do (17621412), Vo Linh Tu (9270944), Dang The Hung (17930180), Duong Hoang Loc (17930165), Van Binh (17930159), Tran Thi Hong Nguyen (17930168), Hong-Han Huynh (17930171), Tran Dinh Trung (17930174), Truong Van Dat (9270950), Dao Ngoc Hien Tam (9270932), Nguyen Nhat Anh Quang (17930156)   +16 more
core   +1 more source

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite

International Journal of Nanomedicine, 2012
Samer Hasan Hussein Al Ali1, Mothanna Al-Qubaisi2, Mohd Zobir Hussein1,3, Maznah Ismail2,4, Zulkarnain Zainal1, Muhammad Nazrul Hakim51Department of Chemistry, Faculty of Science, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Advanced ...
Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN   +5 more
doaj  

Digital pharmacoepidemiology of angiotensin-converting enzyme inhibitors in Russia. [PDF]

Front Pharmacol
Kotlyarov S, Kotlyarova A.
europepmc   +1 more source

Clinical analyses of angiotensin-converting enzyme inhibitor users presenting with cough to a chest diseases outpatient clinic: A single-center retrospective study. [PDF]

J Int Med Res
Bektaş Aksoy H, Günaydın S.
europepmc   +1 more source

Nebivolol treatment improves hypertension-induced endothelial cell dysfunction by reducing TGF-β1-dependent senescence and normalizing mitochondrial indices. [PDF]

J Hypertens
Uruski P, Mikuła-Pietrasik J, Tykarski A, Książek K.   +3 more
europepmc   +1 more source

Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: win ratio analysis of ADVANCE trial. [PDF]

Eur Heart J Cardiovasc Pharmacother
Bompoint S, Billot L, Patel A, Woodward M, Harris K, Harrap S, Mancia G, Poulter N, Chalmers J.   +8 more
europepmc   +1 more source

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular and non-cardiovascular outcomes in patients at high/very-high cardiovascular risk without heart failure: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials ^†. [PDF]

Eur Heart J Open
Masi S, Savarese G, Orsini N, Strauss MH.   +3 more
europepmc   +1 more source

Machine learning-based prediction model for drug target identification and MASH improvement: a comprehensive analysis of biochemical and ferroptosis/autophagy biomarkers. [PDF]

J Physiol Biochem
Matboli M, Elanwar A, Khaled R, Khaled A, Eltantawy EHB, Hamam GG, Ahmed MY, Fouad M, Tarek AA, Elmasry M, El-Shafei MM, Aboulhoda BE, Diab GI, Aboughaleb IH.   +13 more
europepmc   +1 more source

Behavioral Effects of Renin-Angiotensin System Modulators in a Rotenone-Induced Model of Parkinson's Disease in Wistar Albino Rats. [PDF]

Cureus
Kg P, K S, Mantri A, Chavan M, K MB, Jaju S.   +5 more
europepmc   +1 more source